Could a tiny dose of naltrexone ease ME/CFS fatigue?
NCT ID NCT07285473
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a low dose of naltrexone can reduce fatigue in people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Researchers will enroll 75 adults from Alabama and track their fatigue levels weekly through online surveys. The goal is to find the best dose for symptom relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35243, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a High-Fat diet reset energy in long COVID?
- Scientists probe the mysterious crash that defines ME/CFS
- Brain retraining trial aims to ease chronic fatigue and long COVID symptoms
- Acupuncture needles aim to clear COVID brain fog in new trial
- Scientists launch study to uncover what drives chronic fatigue syndrome
- Fatigue study seeks to unravel mystery of exhaustion